This webinar was held on April 2, 2020.
The COVID-19 pandemic has significantly impacted the treatment of individuals with substance use disorder (SUD), including changes in the administration of Medications for Addiction Treatment (MAT), new telehealth rules and billing procedures, and other emerging protocols and regulations designed to ensure individuals with SUD continue to receive the best care possible.
During this webinar, HMA addiction experts Scott Haga and Shannon Robinson outlined how providers and patients can best navigate this changing landscape, with a special emphasis on the opportunities and risks associated with treating SUD during the pandemic.
- Find out how the COVID-19 pandemic significantly increases the risk of SUD relapse and overdose-related fatalities.
- Understand federal regulatory changes to the practice of prescribing MAT for opioid use disorder, including changes from DEA, SAMHSA, Office of Civil Rights and more.
- Obtain best practices and billing guidelines for the use of telehealth to treat individuals with SUD remotely.
Scott Haga, MPAS PA-C, Senior Consultant, Lansing, MI
Shannon Robinson, MD, FASAM, Principal, Costa Mesa, CA
As mentioned in the webinar, the Telehealth Readiness Questionnaire is also available.